Retrospective review of prostate biopsies performed in Hospital La California, San José, Costa Rica from January 2018 until December 2019.

Authors

  • Mario González

DOI:

https://doi.org/10.54212/27068048.v8i1.27

Keywords:

Prostate cancer, prostate biopsy, twelve cylinders

Abstract

Objectives: To evaluate the indications for trans rectal prostate biopsies and to correlate them with the eventual diagnosis for prostate cancer. To differentiate if digital rectal examination (DRE) or prostate specific antigen (PSA) have a greater positive predictive value. To determine if the current prostate biopsy protocol in our center is safe for our patients.

Materials and methods: A retrospective review of medical files of patients submitted for a trans rectal prostate biopsy at Hospital La California from January 2018 to December 2019. The samples were taken by Dr. Mario Gonzalez (urologist). A total of 200 biopsies were taken, only 168 patients that had complete information in their file such as PSA and DRE were included in the study. The indications for prostate biopsy were a PSA higher o equal to 2.5 ng/ml  and any abnormal finding in the DRE suggesting prostatic malignancy. Complications such as bleeding requiring re admission prior to 12 hours after the biopsy and the appearance of fever above 38.5º C within the the first 24 hours after the biopsy were recorded.

Results and conclusions: From January 2018 until December 2019, 200 prostate biopsies were performed. 168 patients that met the criteria were included in the study. The mean age was 62.5 yrs (median 62 years). The average prostate size was 53.9 gramos. From the total of patients (n=168), 41 presented an abnormal DRE (24.4%). On the other hand, an abnormal PSA (0>2.5 ng/ml) was found in 162 cases (96.4%). Moreover, 22% (37/168) patients had both abnormal PSA and DRE.

Regarding clinical correlation with pathological findings, 35.1% of the cases resulted in adenocarcinoma of the prostate (59/168). In addition,  abnormal DRE was associated with prostate cancer (CaP)  in 18.4% (31/168) cases. When abnormal PSA and DRE were combined, 29/168 cases (17.2%) were positive. 

There were no hospital re admissions (0/168) and only 4/168 presented a post biopsy prostatitis (0.02%), they were managed with intra muscular antibiotics and none required hospital admission.

Downloads

Download data is not yet available.

References

Streicher J, Meyerson BL, Karivedu V, Sidana A. A review of optimal prostate biopsy: indications and techniques. Ther Adv Urol. 2019;11:1756287219870074. Published 2019 Aug 28. https://doi.org/10.1177/1756287219870074 DOI: https://doi.org/10.1177/1756287219870074

Martorana E, Pirola GM, Aisa MC, et al. Prostate MRI and transperineal TRUS/MRI fusion biopsy for prostate cancer detection: clinical practice updates. Turk J Urol. 2019;45(4):237‐244. Published 2019 Jul 1. https://doi.org/10.5152/tud.2019.19106 DOI: https://doi.org/10.5152/tud.2019.19106

Moe A, Hayne D. Transrectal ultrasound biopsy of the prostate: does it still have a role in prostate cancer diagnosis? Transl Androl Urol 2019. DOI: https://doi.org/10.21037/tau.2019.09.37

NCCN. Clinical practice guidelines in oncology, prostate cancer early detection. Version 2.2018, https://www.nccn.org/professionals/physician_gls/pdf/prostate_detection.pdf (2018)

Carter HB, Albertsen PC, Barry MJet al. Early detection of prostate cancer: AUA Guideline. J Urol 2013; 190: 419–426.[PMC free article][PubMed][Google Scholar]. https://doi.org/10.1016/j.juro.2013.04.119 DOI: https://doi.org/10.1016/j.juro.2013.04.119

Park R, Gyorfi J, Dewan K, Kirimanjeswara G, Clark JY, Kaag MG, Topical rectal antiseptic at time of prostate biopsy: how a resident patient safety project has evolved into institutional practice. Int Urol Nephrol. 2018 Sep;50(9):1563-1568. doi: 10.1007/s11255-018-1937-3. Epub 2018 Jul 17. https://doi.org/10.1007/s11255-018-1937-3 DOI: https://doi.org/10.1007/s11255-018-1937-3

BABAIAN, R.J.; TOI, A.; KAMOI, K. y cols.: “A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy”. J. Urol., 163: 152, 2000. https://doi.org/10.1097/00005392-200001000-00036 DOI: https://doi.org/10.1097/00005392-200001000-00036

Felipe Herranz Amo, José María Díez Cordero y Ramiro Cabello Benavente. EVOLUCIÓN DE LA TÉCNICA DE BIOPSIA TRANSRECTAL ECODIRIGIDA DE LA PRÓSTATA. Servicio de Urología. Hospital General Universitario Gregorio Marañón. Madrid. España. Arch. Esp. Urol., 59, 4 (385-396), 2006. https://doi.org/10.4321/S0004-06142006000400008 DOI: https://doi.org/10.4321/S0004-06142006000400008

Jones, D., Friend, C., Dreher, A. et al. The diagnostic test accuracy of rectal examination for prostate cancer diagnosis in symptomatic patients: a systematic review. BMC Fam Pract 19, 79 (2018). https://doi.org/10.1186/s12875-018-0765-y DOI: https://doi.org/10.1186/s12875-018-0765-y

Fritz H. Schröder, Arto Boeken Kruger, John Rietbergen, Ries Kranse, Paul van der Maas, Petra Beemsterboer, Robert Hoedemaeker, Evaluation of the Digital Rectal Examination as a Screening Test for Prostate Cancer, JNCI: Journal of the National Cancer Institute, Volume 90, Issue 23, 2 December 1998, Pages 1817–1823, https://doi.org/10.1093/jnci/90.23.1817 DOI: https://doi.org/10.1093/jnci/90.23.1817

Published

2020-06-30

How to Cite

González, M. (2020). Retrospective review of prostate biopsies performed in Hospital La California, San José, Costa Rica from January 2018 until December 2019. Revista Guatemalteca De Urología, 8(1), 15–19. https://doi.org/10.54212/27068048.v8i1.27

Issue

Section

original articles